Quick Links: Skip to main page content
Skip to Search
Skip to Topics Menu
Skip to Common Links
U.S. Food & Drug Administration
Follow FDA
En Español
Search FDA
Home
Food
Drugs
Medical Devices
Radiation-Emitting Products
Vaccines, Blood & Biologics
Animal & Veterinary
Cosmetics
Tobacco Products
Pediatric Studies Characteristics - Detail
FDA Home
Pediatrics
Pediatric Studies Characteristics
Detail
-
Please note:
JavaScript must be enabled for this application to work properly.
Check your settings
if you are unsure if your JavaScript is enabled.
Approval Date:
12/22/2009
Trade Name:
Flomax
Generic or Proper Name (*):
tamsulosin
Indications Studied:
Treatment of elevated detrusor leak point pressure associated with neurological disorder
Therapeutic Category:
Urology
Ages Studied:
2-16 years
Study #:
1
Study Type:
Efficacy/Safety/Pharmacokinetic
Study Design:
Single-Blind/Placebo/Parallel Group/Population Pharmacokinetic
No Patients:
161
No Centers:
3
No Countries:
3
BPCA(B), PREA(P):
B
Asian:
89
Black:
10
Other:
0
White:
44
Native Hawaiian or Pacific Islander:
18
American Indian/Alaska Native:
0
Hispanic/Latino:
25
Non-Hispanic/Non Latino:
136
-
-